Camlin Fine Sciences Ltd Share Price ₹137

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Camlin Fine Sciences Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	427	420	406	386	377	381	417	431	432	424	460	441	425
Expenses +	383	381	381	363	345	352	366	375	370	405	427	420	404
Operating Profit	44	39	25	23	31	29	52	56	62	19	33	21	21
OPM %	10%	9%	6%	6%	8%	8%	12%	13%	14%	4%	7%	5%	5%
Other Income +	-8	6	2	2	-96	-15	-151	-8	-22	3	-4	-24	103
Interest	10	10	20	14	16	23	26	34	15	16	19	17	23
Depreciation	18	19	19	21	13	15	17	14	17	17	19	16	21
Profit before tax	8	16	-12	-10	-94	-23	-142	-0	8	-11	-9	-37	80
Tax %	59%	25%	72%	47%	-13%	48%	-18%	2,164%	98%	-0%	65%	-0%	-8%
Net Profit +	3	12	-21	-14	-82	-35	-116	-7	0	-11	-15	-37	86
EPS in Rs	0.52	0.83	-1.03	-0.63	-4.11	-1.81	-5.33	-0.22	-0.04	-0.53	-0.76	-1.89	4.59

Financials of Camlin Fine Sciences Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	558	489	534	721	892	1,049	1,187	1,412	1,682	1,454	1,667	1,723
Expenses +	474	397	502	705	819	914	1,000	1,254	1,471	1,284	1,447	1,616
Operating Profit	84	92	32	16	73	135	187	158	211	170	220	107
OPM %	15%	19%	6%	2%	8%	13%	16%	11%	13%	12%	13%	6%
Other Income +	9	-1	14	12	14	3	5	33	-4	-142	-203	60
Interest	24	24	31	32	41	48	42	41	64	70	111	73
Depreciation	16	17	22	27	29	33	44	56	63	56	64	71
Profit before tax	53	50	-6	-31	17	58	105	94	80	-99	-158	23
Tax %	-4%	28%	-26%	-22%	82%	49%	38%	36%	50%	6%	0%	-2%
Net Profit +	55	36	-4	-24	3	30	65	60	40	-105	-158	24
EPS in Rs	5.11	3.30	-0.96	-2.18	0.04	2.23	3.56	3.45	2.96	-4.94	-7.40	1.44
Dividend Payout %	8%	12%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Financials of Camlin Fine Sciences Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	12	12	12	13	16	16	17	19	19
Reserves	125	167	202	359	359	391	631	732	804	848	883	1,022
Borrowings +	160	180	331	373	461	539	550	646	801	683	681	720
Other Liabilities +	131	123	126	273	255	290	282	396	425	424	454	563
Total Liabilities	426	479	669	1,016	1,087	1,232	1,475	1,790	2,045	1,972	2,037	2,324
Fixed Assets +	106	140	201	278	272	306	584	601	858	816	704	887
CWIP	3	25	8	14	59	179	24	215	43	46	10	33
Investments	1	1	19	115	11	7	7	7	8	8	61	30
Other Assets +	316	313	442	609	745	740	861	966	1,136	1,102	1,262	1,373
Total Assets	426	479	669	1,016	1,087	1,232	1,475	1,790	2,045	1,972	2,037	2,324

Financials of Camlin Fine Sciences Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	46	72	-9	-15	-9	86	117	145	51	139	27
Cash from Investing Activity +	-26	-66	-70	-149	-2	-90	-133	-249	-125	-66	-75
Cash from Financing Activity +	-15	-7	91	182	26	3	39	136	60	-86	72
Net Cash Flow	4	-1	13	18	15	-1	23	32	-14	-13	24
Free Cash Flow	19	5	-39	-34	-78	-48	34	-68	-93	79	-16
CFO/OP	68%	91%	5%	-33%	10%	77%	82%	111%	34%	110%	30%

Financials of Camlin Fine Sciences Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	74	56	99	104	86	88	83	77	66	72	72	79
Inventory Days	184	311	277	207	219	204	200	178	255	256	233	199
Days Payable	144	171	110	154	127	119	99	112	129	154	162	200
Cash Conversion Cycle	114	196	266	157	178	173	184	143	192	174	143	78
Working Capital Days	12	1	-6	19	43	22	55	40	42	51	35	23
ROCE %	28%	24%	5%	0%	7%	11%	13%	10%	10%	8%	11%	4%